Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

TudorSN Inhibitors

TudorSN inhibitors belong to a specific chemical class that plays a crucial role in the realm of molecular biology and cellular processes. These inhibitors are designed to target TudorSN, a protein that belongs to the Tudor domain-containing family. The Tudor domain is a conserved protein motif found in various organisms and is known for its ability to recognize and bind to methylated proteins and nucleic acids. TudorSN, specifically, is involved in the recognition and binding of methylated arginine residues on proteins, playing a vital role in processes like RNA metabolism, transcriptional regulation, and signal transduction.

The chemical class of TudorSN inhibitors comprises small molecules or compounds that are strategically designed to disrupt the interaction between TudorSN and its methylated substrates. These inhibitors typically work by binding to TudorSN and its binding to methylated targets, thus interfering with the normal cellular functions associated with TudorSN. By doing so, TudorSN inhibitors have the potential to impact various cellular processes where TudorSN is involved, potentially leading to downstream effects on gene expression, RNA processing, and other essential biological functions. The development and study of TudorSN inhibitors hold significant promise in advancing our understanding of the molecular mechanisms underlying epigenetic regulation and methylated protein interactions, shedding light on fundamental cellular processes that are essential for the proper functioning of living organisms.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GW 5074

220904-83-6sc-200639
sc-200639A
5 mg
25 mg
$106.00
$417.00
10
(1)

GW5074 is a c-Raf kinase inhibitor that influences MAPK/ERK pathways, potentially affecting downstream proteins such as TudorSN by altering transcription regulation.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can influence cellular processes including apoptosis and transcription where TudorSN may play a role.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can affect various signaling pathways, potentially impacting mechanisms where TudorSN is involved.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK inhibitor that prevents the activation of MAPK/ERK pathway, which can indirectly affect TudorSN activity in the cell.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor, which may alter stress responses and cytokine production, thereby potentially influencing TudorSN-related pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor that can affect protein synthesis and autophagy, processes that could involve TudorSN.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that can disrupt signaling pathways and thus indirectly inhibit the function of TudorSN.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Triciribine is an Akt inhibitor that can disrupt cell survival and growth signals, potentially impacting TudorSN through these pathways.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is an inhibitor of MEK, which can affect the MAPK/ERK pathway, potentially altering the activity of TudorSN.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$96.00
$355.00
69
(1)

Dorsomorphin is an inhibitor of AMPK, which can influence cellular energy homeostasis and potentially affect TudorSN-related processes.